Gene
TADA2A
Entrez Gene ID | 6871 (See on NCBI) |
Description | transcriptional adaptor 2A |
Gene Synonyms | ADA2, ADA2A, TADA2L, hADA2 |
Node consisting of this Gene | TADA2A TADA2L |
Networks including this gene
GSE10063_top8000 - GSE10063 - SiGN-BN NNSR | Effects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia |
GSE10138_top8000 - GSE10138 - SiGN-BN NNSR | A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia (Duke_VA) |
GSE10358_top8000 - GSE10358 - SiGN-BN NNSR | Discovery and validation of expression data for the Genomics of Acute Myeloid Leukemia Program at Washington University. |
GSE10972_top8000 - GSE10972 - SiGN-BN NNSR | Colon cancer |
GSE11121_top8000 - GSE11121 - SiGN-BN NNSR | The humoral immune system has a key prognostic impact in node-negative breast cancer |
GSE11582_top8000 - GSE11582 - SiGN-BN NNSR | Genetic Analysis of Human Traits In-Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines |
GSE12093_top8000 - GSE12093 - SiGN-BN NNSR | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
GSE12195_top8000 - GSE12195 - SiGN-BN NNSR | Mutations of multiple genes deregulate the NF-kB pathway in diffuse large B cell lymphoma |
GSE12276_top8000 - GSE12276 - SiGN-BN NNSR | Expression data from primary breast tumors |
GSE12391_top8000 - GSE12391 - SiGN-BN NNSR | Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi |
GSE12428_top8000 - GSE12428 - SiGN-BN NNSR | Current smoking-specific gene expression signature in bronchial epithelium is enhanced in squamous cell lung cancer |
GSE12622_top8000 - GSE12622 - SiGN-BN NNSR | Tumor-associated stroma derived from primary clinical breast cancer samples (II) |
GSE13009_top8000 - GSE13009 - SiGN-BN NNSR | MCF7 EGF, HRG stimulation |
GSE13255_top8000 - GSE13255 - SiGN-BN NNSR | Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with NonSmall Cell Lung Cancer. |
GSE13601_top8000 - GSE13601 - SiGN-BN NNSR | Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators |
GSE14315_top8000 - GSE14315 - SiGN-BN NNSR | Effects of demethylation on lung cancer cell lines |
GSE14333_top8000 - GSE14333 - SiGN-BN NNSR | Expression data from 290 primary colorectal cancers |
GSE14764_top8000 - GSE14764 - SiGN-BN NNSR | A Prognostic Gene Expression Index in Ovarian Cancer |
GSE15212_top8000 - GSE15212 - SiGN-BN NNSR | Identification and validation of NOL5A and RPS2 as potential therapeutic targtes in colorectal cancer |
GSE15852_top8000 - GSE15852 - SiGN-BN NNSR | Expression data from human breast tumors and their paired normal tissues |
GSE15966_top8000 - GSE15966 - SiGN-BN NNSR | Gene expression signature predictive of rapid response to imatinib mesylate in Gastrointestinal Stromal Tumor (GIST) |
GSE16237_top8000 - GSE16237 - SiGN-BN NNSR | Expression data of human neuroblastoma tissue samples |
GSE16987_top8000 - GSE16987 - SiGN-BN NNSR | A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis |
GSE17705_top8000 - GSE17705 - SiGN-BN NNSR | Endocrine Sensitivity Index Validation Dataset |
GSE18684_top8000 - GSE18684 - SiGN-BN NNSR | Fine mapping of androgen regulated genes in LNCaP cells |
GSE19069_top8000 - GSE19069 - SiGN-BN NNSR | Molecular signatures in peripheral T-cell lymphoma (PTCL) |
GSE19417_top8000 - GSE19417 - SiGN-BN NNSR | Human esophageal adenocarcinomas |
GSE20181_top8000 - GSE20181 - SiGN-BN NNSR | Letrozole (Femara) early and late responses to treatment |
GSE20194_top8000 - GSE20194 - SiGN-BN NNSR | MAQC-II Project: human breast cancer (BR) data set |
GSE20257_top8000 - GSE20257 - SiGN-BN NNSR | Smoking-induced Disarray of the Apical Junctional Complex Gene Expression Architecture in the Human Airway Epithelium |
GSE20271_top8000 - GSE20271 - SiGN-BN NNSR | Expression data from breast cancer FNA biopsies from patients |
GSE2034_top8000 - GSE2034 - SiGN-BN NNSR | Breast cancer relapse free survival |
GSE20685_top8000 - GSE20685 - SiGN-BN NNSR | Microarray-based molecular subtyping of breast cancer |
GSE21029_top8000 - GSE21029 - SiGN-BN NNSR | The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (CLL) |
GSE2113_top8000 - GSE2113 - SiGN-BN NNSR | Plasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma |
GSE21452_top8000 - GSE21452 - SiGN-BN NNSR | Integrated genomic profiling in mantle cell lymphoma |
GSE22093_top8000 - GSE22093 - SiGN-BN NNSR | Expression data from breast cancer FNA biopsies from patients |
GSE22597_top8000 - GSE22597 - SiGN-BN NNSR | Expression data from Fine Needle Aspiration (FNA) biopsies from breast cancer patients |
GSE2294_top8000 - GSE2294 - SiGN-BN NNSR | A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors |
GSE23177_top8000 - GSE23177 - SiGN-BN NNSR | Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs. |
GSE23772_top8000 - GSE23772 - SiGN-BN NNSR | Why does HAMLET preferentially kill tumor cells? p38-dependent death in tumor but up-regulation of innate immunity in healthy, differentiated cells |
GSE23878_top8000 - GSE23878 - SiGN-BN NNSR | Genome Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy |
GSE23991_top8000 - GSE23991 - SiGN-BN NNSR | Effect of zebularine on primary human liver cancer cell lines |
GSE24080_top8000 - GSE24080 - SiGN-BN NNSR | MAQC-II Project: Multiple myeloma (MM) data set |
GSE24185_top8000 - GSE24185 - SiGN-BN NNSR | Gene transcription signature of obesity in breast cancer |
GSE25055_top8000 - GSE25055 - SiGN-BN NNSR | Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
GSE25065_top8000 - GSE25065 - SiGN-BN NNSR | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
GSE25066_top8000 - GSE25066 - SiGN-BN NNSR | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
GSE2549_top8000 - GSE2549 - SiGN-BN NNSR | Malignant pleural mesothelioma |
GSE2603_top8000 - GSE2603 - SiGN-BN NNSR | Subpopulations of MDA-MB-231 and Primary Breast Cancers |
GSE26549_top8000 - GSE26549 - SiGN-BN NNSR | Gene Expression Profiling Predicts the Development of Oral Cancer |
GSE26599_top8000 - GSE26599 - SiGN-BN NNSR | Gene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2 overexpressing human mammary epithelial cell lines |
GSE27480_top8000 - GSE27480 - SiGN-BN NNSR | Gene-expression analysis of Oncostatin-M (OSM) signalling in cervical squamous cell carcinomas over-expressing the Oncostatin-M receptor (OSMR) |
GSE28497_top8000 - GSE28497 - SiGN-BN NNSR | New markers for minimal residual disease detection in acute lymphoblastic leukemia |
GSE29598_top8000 - GSE29598 - SiGN-BN NNSR | A Methodology for Utilization of Predictive Genomic Signatures in FFPE Samples |
GSE2990_top8000 - GSE2990 - SiGN-BN NNSR | Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis |
GSE30375_top8000 - GSE30375 - SiGN-BN NNSR | Gene expression data from sorted and unsorted primary human acute myeloid leukemia (AML) samples |
GSE31245_top8000 - GSE31245 - SiGN-BN NNSR | Unique gene expression profile based upon pathologic response in epithelial ovarian cancer |
GSE3143_top8000 - GSE3143 - SiGN-BN NNSR | Breast Cancer Dataset |
GSE3149_top8000 - GSE3149 - SiGN-BN NNSR | Ovarian Cancer Dataset |
GSE31519_top8000 - GSE31519 - SiGN-BN NNSR | A Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer |
GSE3726_top8000 - GSE3726 - SiGN-BN NNSR | Prognostic gene signatures can be measured with samples stored in RNAlater |
GSE3960_top8000 - GSE3960 - SiGN-BN NNSR | Classification of neuroblastoma by integrating gene expression pattern with regional alterations in DNA copy number |
GSE4183_top8000 - GSE4183 - SiGN-BN NNSR | Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature |
GSE4290_top8000 - GSE4290 - SiGN-BN NNSR | Expression data of glioma samples from Henry Ford Hospital |
GSE4536_top8000 - GSE4536 - SiGN-BN NNSR | Tumor stem cells more closely mirror the phenotype and genotype of primary human tumors than do cancer cell lines |
GSE4573_top8000 - GSE4573 - SiGN-BN NNSR | Gene expression signatures for predicting prognosis of squamous cell lung carcinomas |
GSE5327_top8000 - GSE5327 - SiGN-BN NNSR | Breast cancer relapse free survival and lung metastasis free survival |
GSE5364_top8000 - GSE5364 - SiGN-BN NNSR | A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers |
GSE5462_top8000 - GSE5462 - SiGN-BN NNSR | Letrozole (Femara) early response to treatment |
GSE5851_top8000 - GSE5851 - SiGN-BN NNSR | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
GSE5900_top8000 - GSE5900 - SiGN-BN NNSR | Gene Expression of Bone Marrow Plasma Cells from Healthy Donors (N=22), MGUS (N=44), and Smoldering Myeloma (N=12) |
GSE6462_top8000 - GSE6462 - SiGN-BN NNSR | MCF7 dose response |
GSE6477_top8000 - GSE6477 - SiGN-BN NNSR | Expression data from different stages of plasma cell neoplasm |
GSE6481_top8000 - GSE6481 - SiGN-BN NNSR | Gene Expression Analysis of Soft Tissue Sarcomas: Characterization & Reclassification of Malignant Fibrous Histiocytoma |
GSE6956_top8000 - GSE6956 - SiGN-BN NNSR | Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men |
GSE7208_top8000 - GSE7208 - SiGN-BN NNSR | Expression data from 59 human colon tumor tissue samples |
GSE7390_top8000 - GSE7390 - SiGN-BN NNSR | Strong Time Dependence of the 76-Gene Prognostic Signature |
GSE7670_top8000 - GSE7670 - SiGN-BN NNSR | Expression data from Lung cancer |
GSE7849_top8000 - GSE7849 - SiGN-BN NNSR | Age-Specific Differences of Oncogenic Pathway Deregulation Seen in Human Breast Tumors |
GSE8057_top8000 - GSE8057 - SiGN-BN NNSR | Expression data from ovarian cancer cells with time-course and concentration-profiles |
GSE8401_top8000 - GSE8401 - SiGN-BN NNSR | Gene Signature for Aggression of Melanoma Metastases - Melanoma Metastasis |
GSE8481_top8000 - GSE8481 - SiGN-BN NNSR | Various human cell types |
GSE8546_top8000 - GSE8546 - SiGN-BN NNSR | Gene Expression Changes in Myeloma Cells Following Short Term In-vivo Drug Exposure |
GSE8581_top8000 - GSE8581 - SiGN-BN NNSR | Human Chronic Obstructive Pulmonary Disorder (COPD) Biomarker |
GSE8835_top8000 - GSE8835 - SiGN-BN NNSR | Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. |
GSE9014_top8000 - GSE9014 - SiGN-BN NNSR | Tumor-associated stroma derived from primary clinical breast cancer samples |
GSE9169_top8000 - GSE9169 - SiGN-BN NNSR | Gene expression during neuronal differentiation in two subtypes of SH-SY5Y |
GSE9750_top8000 - GSE9750 - SiGN-BN NNSR | Identification of gene expression profiles in cervical cancer |
GSE10063_top500tf - GSE10063 - SiGN-BN HC+Bootstrap | Effects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia |
GSE10138_top500tf - GSE10138 - SiGN-BN HC+Bootstrap | A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia (Duke_VA) |
GSE10327_top500tf - GSE10327 - SiGN-BN HC+Bootstrap | mRNA expression data of 62 human medulloblastoma tumors |
GSE10358_top500tf - GSE10358 - SiGN-BN HC+Bootstrap | Discovery and validation of expression data for the Genomics of Acute Myeloid Leukemia Program at Washington University. |
GSE10972_top500tf - GSE10972 - SiGN-BN HC+Bootstrap | Colon cancer |
GSE11121_top500tf - GSE11121 - SiGN-BN HC+Bootstrap | The humoral immune system has a key prognostic impact in node-negative breast cancer |
GSE11582_top500tf - GSE11582 - SiGN-BN HC+Bootstrap | Genetic Analysis of Human Traits In-Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines |
GSE11869_top500tf - GSE11869 - SiGN-BN HC+Bootstrap | The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. |
GSE12093_top500tf - GSE12093 - SiGN-BN HC+Bootstrap | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
GSE12195_top500tf - GSE12195 - SiGN-BN HC+Bootstrap | Mutations of multiple genes deregulate the NF-kB pathway in diffuse large B cell lymphoma |
GSE12276_top500tf - GSE12276 - SiGN-BN HC+Bootstrap | Expression data from primary breast tumors |
GSE12391_top500tf - GSE12391 - SiGN-BN HC+Bootstrap | Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi |
GSE12428_top500tf - GSE12428 - SiGN-BN HC+Bootstrap | Current smoking-specific gene expression signature in bronchial epithelium is enhanced in squamous cell lung cancer |
GSE12622_top500tf - GSE12622 - SiGN-BN HC+Bootstrap | Tumor-associated stroma derived from primary clinical breast cancer samples (II) |
GSE12667_top500tf - GSE12667 - SiGN-BN HC+Bootstrap | Discovery of somatic mutations in lung adenocarcinomas |
GSE12777_top500tf - GSE12777 - SiGN-BN HC+Bootstrap | Gene expression profiling of 51 human breast cancer cell lines |
GSE13009_top500tf - GSE13009 - SiGN-BN HC+Bootstrap | MCF7 EGF, HRG stimulation |
GSE13067_top500tf - GSE13067 - SiGN-BN HC+Bootstrap | Expression data from primary colorectal cancers |
GSE13255_top500tf - GSE13255 - SiGN-BN HC+Bootstrap | Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with NonSmall Cell Lung Cancer. |
GSE13294_top500tf - GSE13294 - SiGN-BN HC+Bootstrap | Expression data from primary colorectal cancers |
GSE13601_top500tf - GSE13601 - SiGN-BN HC+Bootstrap | Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators |
GSE13898_top500tf - GSE13898 - SiGN-BN HC+Bootstrap | Robust prognostic biomarkers for EAC identified by systems-level characterization of tumor transcriptome |
GSE14315_top500tf - GSE14315 - SiGN-BN HC+Bootstrap | Effects of demethylation on lung cancer cell lines |
GSE14333_top500tf - GSE14333 - SiGN-BN HC+Bootstrap | Expression data from 290 primary colorectal cancers |
GSE14764_top500tf - GSE14764 - SiGN-BN HC+Bootstrap | A Prognostic Gene Expression Index in Ovarian Cancer |
GSE14925_top500tf - GSE14925 - SiGN-BN HC+Bootstrap | Expression data from Non small cell lung cancer cell lines |
GSE15212_top500tf - GSE15212 - SiGN-BN HC+Bootstrap | Identification and validation of NOL5A and RPS2 as potential therapeutic targtes in colorectal cancer |
GSE15396_top500tf - GSE15396 - SiGN-BN HC+Bootstrap | Peripheral blood mononuclear, DU145, and HCT116 cells treated with a CDK inhibitor |
GSE15459_top500tf - GSE15459 - SiGN-BN HC+Bootstrap | Gastric Cancer Project '08 (Singapore Patient Cohort) |
GSE15852_top500tf - GSE15852 - SiGN-BN HC+Bootstrap | Expression data from human breast tumors and their paired normal tissues |
GSE15966_top500tf - GSE15966 - SiGN-BN HC+Bootstrap | Gene expression signature predictive of rapid response to imatinib mesylate in Gastrointestinal Stromal Tumor (GIST) |
GSE16237_top500tf - GSE16237 - SiGN-BN HC+Bootstrap | Expression data of human neuroblastoma tissue samples |
GSE16455_top500tf - GSE16455 - SiGN-BN HC+Bootstrap | Indolent MCL identified by genomic and gene expression profiling |
GSE16581_top500tf - GSE16581 - SiGN-BN HC+Bootstrap | Genomic landscape of meningiomas: gene expression |
GSE16987_top500tf - GSE16987 - SiGN-BN HC+Bootstrap | A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis |
GSE17705_top500tf - GSE17705 - SiGN-BN HC+Bootstrap | Endocrine Sensitivity Index Validation Dataset |
GSE17764_top500tf - GSE17764 - SiGN-BN HC+Bootstrap | Expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients |
GSE18684_top500tf - GSE18684 - SiGN-BN HC+Bootstrap | Fine mapping of androgen regulated genes in LNCaP cells |
GSE19027_top500tf - GSE19027 - SiGN-BN HC+Bootstrap | Antioxidant response gene expression in the bronchial airway epithelial cells of smokers at risk for lung cancer |
GSE19069_top500tf - GSE19069 - SiGN-BN HC+Bootstrap | Molecular signatures in peripheral T-cell lymphoma (PTCL) |
GSE20181_top500tf - GSE20181 - SiGN-BN HC+Bootstrap | Letrozole (Femara) early and late responses to treatment |
GSE20194_top500tf - GSE20194 - SiGN-BN HC+Bootstrap | MAQC-II Project: human breast cancer (BR) data set |
GSE20257_top500tf - GSE20257 - SiGN-BN HC+Bootstrap | Smoking-induced Disarray of the Apical Junctional Complex Gene Expression Architecture in the Human Airway Epithelium |
GSE20271_top500tf - GSE20271 - SiGN-BN HC+Bootstrap | Expression data from breast cancer FNA biopsies from patients |
GSE2034_top500tf - GSE2034 - SiGN-BN HC+Bootstrap | Breast cancer relapse free survival |
GSE20685_top500tf - GSE20685 - SiGN-BN HC+Bootstrap | Microarray-based molecular subtyping of breast cancer |
GSE21029_top500tf - GSE21029 - SiGN-BN HC+Bootstrap | The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (CLL) |
GSE2113_top500tf - GSE2113 - SiGN-BN HC+Bootstrap | Plasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma |
GSE21452_top500tf - GSE21452 - SiGN-BN HC+Bootstrap | Integrated genomic profiling in mantle cell lymphoma |
GSE22093_top500tf - GSE22093 - SiGN-BN HC+Bootstrap | Expression data from breast cancer FNA biopsies from patients |
GSE22597_top500tf - GSE22597 - SiGN-BN HC+Bootstrap | Expression data from Fine Needle Aspiration (FNA) biopsies from breast cancer patients |
GSE2294_top500tf - GSE2294 - SiGN-BN HC+Bootstrap | A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors |
GSE23120_top500tf - GSE23120 - SiGN-BN HC+Bootstrap | Basal gene expression data from Human Variation Panel |
GSE23177_top500tf - GSE23177 - SiGN-BN HC+Bootstrap | Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs. |
GSE23772_top500tf - GSE23772 - SiGN-BN HC+Bootstrap | Why does HAMLET preferentially kill tumor cells? p38-dependent death in tumor but up-regulation of innate immunity in healthy, differentiated cells |
GSE23878_top500tf - GSE23878 - SiGN-BN HC+Bootstrap | Genome Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy |
GSE23991_top500tf - GSE23991 - SiGN-BN HC+Bootstrap | Effect of zebularine on primary human liver cancer cell lines |
GSE24080_top500tf - GSE24080 - SiGN-BN HC+Bootstrap | MAQC-II Project: Multiple myeloma (MM) data set |
GSE24185_top500tf - GSE24185 - SiGN-BN HC+Bootstrap | Gene transcription signature of obesity in breast cancer |
GSE25055_top500tf - GSE25055 - SiGN-BN HC+Bootstrap | Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
GSE25065_top500tf - GSE25065 - SiGN-BN HC+Bootstrap | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
GSE25066_top500tf - GSE25066 - SiGN-BN HC+Bootstrap | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
GSE2549_top500tf - GSE2549 - SiGN-BN HC+Bootstrap | Malignant pleural mesothelioma |
GSE2603_top500tf - GSE2603 - SiGN-BN HC+Bootstrap | Subpopulations of MDA-MB-231 and Primary Breast Cancers |
GSE26549_top500tf - GSE26549 - SiGN-BN HC+Bootstrap | Gene Expression Profiling Predicts the Development of Oral Cancer |
GSE26599_top500tf - GSE26599 - SiGN-BN HC+Bootstrap | Gene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2 overexpressing human mammary epithelial cell lines |
GSE27480_top500tf - GSE27480 - SiGN-BN HC+Bootstrap | Gene-expression analysis of Oncostatin-M (OSM) signalling in cervical squamous cell carcinomas over-expressing the Oncostatin-M receptor (OSMR) |
GSE2841_top500tf - GSE2841 - SiGN-BN HC+Bootstrap | Expression Profiling of pheochromocytomas of various genetic origins |
GSE28497_top500tf - GSE28497 - SiGN-BN HC+Bootstrap | New markers for minimal residual disease detection in acute lymphoblastic leukemia |
GSE29598_top500tf - GSE29598 - SiGN-BN HC+Bootstrap | A Methodology for Utilization of Predictive Genomic Signatures in FFPE Samples |
GSE2990_top500tf - GSE2990 - SiGN-BN HC+Bootstrap | Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis |
GSE30240_top500tf - GSE30240 - SiGN-BN HC+Bootstrap | Expression data from 5 human cell lines exposed to IR (5 Gy) |
GSE30375_top500tf - GSE30375 - SiGN-BN HC+Bootstrap | Gene expression data from sorted and unsorted primary human acute myeloid leukemia (AML) samples |
GSE31245_top500tf - GSE31245 - SiGN-BN HC+Bootstrap | Unique gene expression profile based upon pathologic response in epithelial ovarian cancer |
GSE3143_top500tf - GSE3143 - SiGN-BN HC+Bootstrap | Breast Cancer Dataset |
GSE3149_top500tf - GSE3149 - SiGN-BN HC+Bootstrap | Ovarian Cancer Dataset |
GSE3151_top500tf - GSE3151 - SiGN-BN HC+Bootstrap | Oncogene Signature Dataset |
GSE31519_top500tf - GSE31519 - SiGN-BN HC+Bootstrap | A Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer |
GSE31552_top500tf - GSE31552 - SiGN-BN HC+Bootstrap | Expression Data from human Lung tissue of Patients with Non Small Cell Lung Cancer (NSCLC) |
GSE3726_top500tf - GSE3726 - SiGN-BN HC+Bootstrap | Prognostic gene signatures can be measured with samples stored in RNAlater |
GSE4183_top500tf - GSE4183 - SiGN-BN HC+Bootstrap | Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature |
GSE4290_top500tf - GSE4290 - SiGN-BN HC+Bootstrap | Expression data of glioma samples from Henry Ford Hospital |
GSE4452_top500tf - GSE4452 - SiGN-BN HC+Bootstrap | Gene Expression Profiles of Multiple Myeloma (N=65) Before Treatment |
GSE4536_top500tf - GSE4536 - SiGN-BN HC+Bootstrap | Tumor stem cells more closely mirror the phenotype and genotype of primary human tumors than do cancer cell lines |
GSE4573_top500tf - GSE4573 - SiGN-BN HC+Bootstrap | Gene expression signatures for predicting prognosis of squamous cell lung carcinomas |
GSE4581_top500tf - GSE4581 - SiGN-BN HC+Bootstrap | Gene Expression Profiles of Multiple Myeloma (N=414) Before Treatment |
GSE5327_top500tf - GSE5327 - SiGN-BN HC+Bootstrap | Breast cancer relapse free survival and lung metastasis free survival |
GSE5364_top500tf - GSE5364 - SiGN-BN HC+Bootstrap | A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers |
GSE5462_top500tf - GSE5462 - SiGN-BN HC+Bootstrap | Letrozole (Femara) early response to treatment |
GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
GSE5900_top500tf - GSE5900 - SiGN-BN HC+Bootstrap | Gene Expression of Bone Marrow Plasma Cells from Healthy Donors (N=22), MGUS (N=44), and Smoldering Myeloma (N=12) |
GSE6462_top500tf - GSE6462 - SiGN-BN HC+Bootstrap | MCF7 dose response |
GSE6477_top500tf - GSE6477 - SiGN-BN HC+Bootstrap | Expression data from different stages of plasma cell neoplasm |
GSE6481_top500tf - GSE6481 - SiGN-BN HC+Bootstrap | Gene Expression Analysis of Soft Tissue Sarcomas: Characterization & Reclassification of Malignant Fibrous Histiocytoma |
GSE6956_top500tf - GSE6956 - SiGN-BN HC+Bootstrap | Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men |
GSE7208_top500tf - GSE7208 - SiGN-BN HC+Bootstrap | Expression data from 59 human colon tumor tissue samples |
GSE7390_top500tf - GSE7390 - SiGN-BN HC+Bootstrap | Strong Time Dependence of the 76-Gene Prognostic Signature |
GSE7553_top500tf - GSE7553 - SiGN-BN HC+Bootstrap | Gene Expression Patterns Involved in the Malignant Transformation and Progression of Metastatic Melanoma |
GSE7670_top500tf - GSE7670 - SiGN-BN HC+Bootstrap | Expression data from Lung cancer |
GSE7849_top500tf - GSE7849 - SiGN-BN HC+Bootstrap | Age-Specific Differences of Oncogenic Pathway Deregulation Seen in Human Breast Tumors |
GSE8057_top500tf - GSE8057 - SiGN-BN HC+Bootstrap | Expression data from ovarian cancer cells with time-course and concentration-profiles |
GSE8401_top500tf - GSE8401 - SiGN-BN HC+Bootstrap | Gene Signature for Aggression of Melanoma Metastases - Melanoma Metastasis |
GSE8481_top500tf - GSE8481 - SiGN-BN HC+Bootstrap | Various human cell types |
GSE8546_top500tf - GSE8546 - SiGN-BN HC+Bootstrap | Gene Expression Changes in Myeloma Cells Following Short Term In-vivo Drug Exposure |
GSE8581_top500tf - GSE8581 - SiGN-BN HC+Bootstrap | Human Chronic Obstructive Pulmonary Disorder (COPD) Biomarker |
GSE8671_top500tf - GSE8671 - SiGN-BN HC+Bootstrap | Transcriptome profile of human colorectal adenomas. |
GSE8835_top500tf - GSE8835 - SiGN-BN HC+Bootstrap | Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. |
GSE9169_top500tf - GSE9169 - SiGN-BN HC+Bootstrap | Gene expression during neuronal differentiation in two subtypes of SH-SY5Y |
GSE9348_top500tf - GSE9348 - SiGN-BN HC+Bootstrap | Expression data from healthy controls and early stage CRC patient's tumor |
GSE9014_top500tf - GSE9014 - SiGN-BN HC+Bootstrap | Tumor-associated stroma derived from primary clinical breast cancer samples |
GSE9750_top500tf - GSE9750 - SiGN-BN HC+Bootstrap | Identification of gene expression profiles in cervical cancer |
(200 networks)